Holdings of AlphaCentric Life Sciences and Healthcare Fund
MUTUAL FUND SERIES TRUST · Original filing · Compare with another fund · Report an error
- Net assets
- 46.6M $ including 44.7M $ in equities, 95.8 %
- Positions
- 60 in 10 countries
- Top ten
- 39.1 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Gilead Sciences Inc | 20,426 | 2.6M $ | 5.53 % |
| 2 | Vertex Pharmaceuticals Inc | 5,002 | 2.5M $ | 5.33 % |
| 3 | AstraZeneca PLC | 11,394 | 2.2M $ | 4.63 % |
| 4 | Roivant Sciences Ltd | 48,355 | 1.7M $ | 3.67 % |
| 5 | Argenx SE | 1,806 | 1.7M $ | 3.59 % |
| 6 | Neurocrine Biosciences Inc | 9,727 | 1.6M $ | 3.51 % |
| 7 | Incyte Corp | 14,451 | 1.6M $ | 3.51 % |
| 8 | Axsome Therapeutics Inc | 6,531 | 1.6M $ | 3.43 % |
| 9 | Apogee Therapeutics Inc | 11,533 | 1.5M $ | 3.28 % |
| 10 | IONIS PHARMACEUTICALS INC | 15,430 | 1.2M $ | 2.62 % |
| 11 | Ascendis Pharma A/S | 4,585 | 1.2M $ | 2.62 % |
| 12 | Insmed Inc | 11,394 | 1.2M $ | 2.60 % |
| 13 | Protagonist Therapeutics Inc | 9,171 | 1.1M $ | 2.41 % |
| 14 | Personalis Inc | 78,924 | 1.1M $ | 2.27 % |
| 15 | Rhythm Pharmaceuticals Inc | 9,449 | 1M $ | 2.25 % |
| 16 | AbbVie Inc | 3,613 | 909.2K $ | 1.95 % |
| 17 | JAZZ PHARMACEUTICALS PLC | 3,613 | 870.6K $ | 1.87 % |
| 18 | Amgen Inc | 2,362 | 855.3K $ | 1.83 % |
| 19 | Biogen Inc | 3,891 | 840.7K $ | 1.80 % |
| 20 | Catalyst Pharmaceuticals Inc | 23,622 | 742.4K $ | 1.59 % |
| 21 | Halozyme Therapeutics Inc | 9,426 | 737.8K $ | 1.58 % |
| 22 | MeiraGTx Holdings plc | 54,469 | 735.9K $ | 1.58 % |
| 23 | Krystal Biotech Inc | 1,945 | 722.9K $ | 1.55 % |
| 24 | Nuvalent Inc | 5,558 | 686.4K $ | 1.47 % |
| 25 | ABIVAX SA | 5,141 | 685.1K $ | 1.47 % |
| 26 | Edgewise Therapeutics Inc | 15,840 | 643.6K $ | 1.38 % |
| 27 | Nurix Therapeutics Inc | 25,845 | 627K $ | 1.34 % |
| 28 | SANOFI SA | 14,590 | 622.4K $ | 1.33 % |
| 29 | ORUKA THERAPEUTICS INC | 6,531 | 621.6K $ | 1.33 % |
| 30 | KYMERA THERAPEUTICS INC | 5,385 | 617.5K $ | 1.32 % |
| 31 | Spyre Therapeutics Inc | 6,670 | 592.2K $ | 1.27 % |
| 32 | BioNTech SE | 6,266 | 583.1K $ | 1.25 % |
| 33 | Agios Pharmaceuticals Inc | 14,173 | 526K $ | 1.13 % |
| 34 | NEWAMSTERDAM PHARMA COMPANY NV | 14,868 | 503.9K $ | 1.08 % |
| 35 | CYTOKINETICS INC | 5,697 | 485.3K $ | 1.04 % |
| 36 | Celldex Therapeutics Inc | 12,784 | 475.7K $ | 1.02 % |
| 37 | Trevi Therapeutics Inc | 24,317 | 453.5K $ | 0.97 % |
| 38 | ALNYLAM PHARMACEUTICALS INC | 1,390 | 418.4K $ | 0.90 % |
| 39 | Veracyte Inc | 6,948 | 408.1K $ | 0.87 % |
| 40 | Candel Therapeutics Inc | 36,683 | 377.8K $ | 0.81 % |
| 41 | NATERA INC | 1,390 | 377.3K $ | 0.81 % |
| 42 | Rezolute Inc | 72,255 | 375.7K $ | 0.81 % |
| 43 | Cullinan Therapeutics Inc | 20,426 | 372K $ | 0.80 % |
| 44 | Crinetics Pharmaceuticals Inc | 9,866 | 369.2K $ | 0.79 % |
| 45 | Xeris Biopharma Holdings Inc | 46,549 | 368.7K $ | 0.79 % |
| 46 | Design Therapeutics Inc | 21,537 | 311.6K $ | 0.67 % |
| 47 | Monte Rosa Therapeutics Inc | 12,645 | 306K $ | 0.66 % |
| 48 | Disc Medicine Inc | 4,030 | 294.8K $ | 0.63 % |
| 49 | Rapport Therapeutics Inc | 6,531 | 272.1K $ | 0.58 % |
| 50 | Arvinas Inc | 30,622 | 254.5K $ | 0.55 % |
| 51 | ICON PLC | 1,390 | 241.5K $ | 0.52 % |
| 52 | Tectonic Therapeutic Inc | 6,948 | 238.8K $ | 0.51 % |
| 53 | Sionna Therapeutics Inc | 4,863 | 213.9K $ | 0.46 % |
| 54 | WAVE LIFE SCIENCES LTD | 35,670 | 207.2K $ | 0.44 % |
| 55 | Intellia Therapeutics Inc | 11,672 | 197.5K $ | 0.42 % |
| 56 | Atrium Therapeutics Inc | 13,478 | 181.3K $ | 0.39 % |
| 57 | IQVIA Holdings Inc | 834 | 161.1K $ | 0.35 % |
| 58 | Annexon Inc | 24,872 | 142K $ | 0.30 % |
| 59 | ADMA Biologics Inc | 10,143 | 84.9K $ | 0.18 % |
| 60 | Aldeyra Therapeutics Inc | 37,656 | 80.2K $ | 0.17 % |
Sector breakdown
- Health care 38.4 %
- Unattributed 61.6 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 74.9 %
- Netherlands 4.9 %
- United Kingdom 4.8 %
- Bermuda 3.8 %
- France 2.9 %
- Denmark 2.7 %
- Ireland 2.5 %
- Cayman Islands 1.6 %
- Germany 1.3 %
- Singapore 0.5 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 48 | 33.5M $ | 74.90 % |
| 2 | Netherlands | 2 | 2.2M $ | 4.88 % |
| 3 | United Kingdom | 1 | 2.2M $ | 4.83 % |
| 4 | Bermuda | 1 | 1.7M $ | 3.83 % |
| 5 | France | 2 | 1.3M $ | 2.92 % |
| 6 | Denmark | 1 | 1.2M $ | 2.74 % |
| 7 | Ireland | 2 | 1.1M $ | 2.49 % |
| 8 | Cayman Islands | 1 | 735.9K $ | 1.65 % |
| 9 | Germany | 1 | 583.1K $ | 1.30 % |
| 10 | Singapore | 1 | 207.2K $ | 0.46 % |
Cite this page
Titelia. "Holdings of AlphaCentric Life Sciences and Healthcare Fund". https://titelia.com/en/funds/S000067055